Orthofix Medical Inc. (NASDAQ:OFIX) Q4 2023 Earnings Call Transcript

Page 3 of 3

Jason Wittes: Wonderful. Appreciate the color. Thanks. I’ll jump back in queue.

Julie Andrews: Yes. And just to amplify, verify on what Massimo said, we had 25% revenue growth in Enabling Technology last year in Q4. I’m sorry.

Operator: We have no further questions. I would like to turn the call back over to Massimo Calafiore for any closing remarks.

Massimo Calafiore: Thank you. Look, I said earlier, I close today by reiterating my enthusiasm to be part of Orthofix and my optimism about the company future. My first two months have really underscored the stability of Orthofix fundamentals and the breadth of portfolio offering. I would also to thank all of our employees worldwide for their commitment to Orthofix and their initiative in maintaining momentum across our whole portfolio. We are going to continue building a dynamic organization dedicated to collaboration, innovation and patient care. 2024 would be a great opportunity for growth and value creation. And, I look forward to providing more granularity on specific initiatives in future updates. Thank you.

Operator: This concludes today’s conference call. Thank you for your participation. You may now disconnect.

Follow Orthofix Medical Inc. (NASDAQ:OFIX)

Page 3 of 3